In Alzheimer’s disease, S100A9 was found to be abundant both in neuronal cells and in amyloid plaques, prompting co-aggregation with amyloid-β (Aβ), the major amyloidogenic peptide in Alzheimer’s disease [18]. The gene discussed is S100A9; the disease is early-onset autosomal dominant Alzheimer disease.